Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

LESSONS LEARNED. Panitumumab shows activity in terms of disease control rate and preventing disease progression but not for tumor shrinkage in head and neck squamous cell cancer for second‐line treatment. Epidermal growth factor receptor (EGFR) copy number gain, a property of tumor cells that theore...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncologist
Главные авторы: Siano, Marco, Molinari, Francesca, Martin, Vittoria, Mach, Nicolas, Früh, Martin, Freguia, Stefania, Corradino, Irene, Ghielmini, Michele, Frattini, Milo, Espeli, Vittoria
Формат: Artigo
Язык:Inglês
Опубликовано: AlphaMed Press 2017
Предметы:
Clinical Trial Results
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5507653/
https://ncbi.nlm.nih.gov/pubmed/28592616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0069
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы